Search by Drug Name or NDC
NDC 36800-0080-01 Athletes Foot 1 g/100g Details
Athletes Foot 1 g/100g
Athletes Foot is a TOPICAL CREAM in the HUMAN OTC DRUG category. It is labeled and distributed by Topco Associates LLC. The primary component is TERBINAFINE HYDROCHLORIDE.
Product Information
NDC | 36800-0080 |
---|---|
Product ID | 36800-080_a7a50c80-4e9a-41b0-ab6d-44c03ed2449d |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Athletes Foot |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Terbinafine Hydrochloride |
Product Type | HUMAN OTC DRUG |
Dosage Form | CREAM |
Route | TOPICAL |
Active Ingredient Strength | 1 |
Active Ingredient Units | g/100g |
Substance Name | TERBINAFINE HYDROCHLORIDE |
Labeler Name | Topco Associates LLC |
Pharmaceutical Class | Allylamine Antifungal [EPC], Allylamine [CS] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA077511 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 36800-0080-01 (36800008001)
NDC Package Code | 36800-080-01 |
---|---|
Billing NDC | 36800008001 |
Package | 1 TUBE in 1 CARTON (36800-080-01) / 15 g in 1 TUBE |
Marketing Start Date | 2007-07-02 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 5019361d-e6af-4c3d-a246-a43358ae914c Details
Uses
Warnings
Directions
|
||
| 1 week between the toes | 2 weeks on the bottom or sides of the foot |
![]() |
Other information
Inactive ingredients
PRINCIPAL DISPLAY PANEL - 15 g Tube Carton
INGREDIENTS AND APPEARANCE
ATHLETES FOOT
terbinafine hydrochloride cream |
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Labeler - Topco Associates LLC (006935977) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Taro Pharmaceuticals Inc. | 206263295 | MANUFACTURE(36800-080) |
Revised: 3/2019
Document Id: a7a50c80-4e9a-41b0-ab6d-44c03ed2449d
Set id: 5019361d-e6af-4c3d-a246-a43358ae914c
Version: 2
Effective Time: 20190308